Departmental News

Jones Comments on the Effects of Taking ADHD Medication While Pregnant

January 23, 2018 by Madi Wood

The Centers for Disease Control (CDC) has recently raised concerns about the effects of prescribed attention deficit hyperactivity disorder (ADHD) medication on unborn children. David Jones, M.D., director of the University of Vermont Medical Center Fetal Diagnostic Center, explains that while there is not much research on this topic, the risk of taking ADHD medication for women considering pregnancy is low.

David Jones, M.D., Professor and Director, Fetal Diagnostic Center

The Centers for Disease Control (CDC) has recently raised concerns about the effects of prescribed attention deficit hyperactivity disorder (ADHD) medication on unborn children. David Jones, M.D., director of the University of Vermont Medical Center Fetal Diagnostic Center, explains that while there is not much research on this topic, the risk of taking ADHD medication for women considering pregnancy is low. "While the data on ADHD medications is still not conclusive due to the small number of studies it appears that overall the risk of birth defects from first trimester use is minimally increased — if it is increased at all,” says Jones.

Read the full story here.

New faculty:

  • Karen George, MD, Associate Professor of Obstetrics, Gynecology and Reproductive Sciences (Division of General Obstetrics and Gynecology).  Dr. George is also Associate Dean for Students at Larner College of Medicine
  • Amanda Kallen, MD,  Associate Professor of of Obstetrics, Gynecology and Reproductive Sciences (Division of Reproductive Endocrinology & Infertility)
  • Anne Dougherty, M.D., Associate Professor of Obstetrics, Gynecology and Reproductive Sciences has now accepted the enhanced role of Director for Gender Equity.